Skip to main content
Mercator Medical logo

Mercator Medical — Investor Relations & Filings

Ticker · MRC ISIN · PLMRCTR00015 LEI · 259400YONW18M3H4WX66 WAR Manufacturing
Open in API
Filings indexed 1,123 across all filing types
Latest filing 2022-07-01 AGM Information
Country PL Poland
Listing WAR MRC

About Mercator Medical

https://en.mercatormedical.eu/

Mercator Medical is a manufacturer of medical gloves and a distributor of single-use medical materials. The company's core product portfolio includes a variety of disposable gloves, such as surgical, diagnostic, sterile, and protective types, alongside other disposable medical supplies. It operates on a dual model: as a manufacturer with a global distribution network selling to numerous countries worldwide, and as a distributor primarily focused on European markets. The business centers on providing single-use medical devices and personal protective equipment.

Recent filings

Filing Released Lang Actions
Zwołanie Nadzwyczajnego Walnego Zgromadzenia - Content (PL)
AGM Information Classification · 98% confidence The document text is a formal announcement in Polish (Zarząd spółki... zwołuje Nadzwyczajne Walne Zgromadzenie Spółki) regarding the convening of an Extraordinary General Meeting (Nadzwyczajne Walne Zgromadzenie). It specifies the date (27 lipca 2022 r.), time, and location, and mentions that the draft resolutions are being made public. This content directly relates to the preparation and announcement of a shareholder meeting, which falls under the scope of AGM Information (AGM-R). Although it is an announcement, the core subject is the meeting itself, making AGM-R more specific than a general RPA or RNS.
2022-07-01 Polish
Wniosek o zwołanie Nadzwyczajnego Walnego Zgromadzenia Mercator Medical S.A.
AGM Information Classification · 100% confidence The document text explicitly states, in both Polish and English, a "Request for convening the Extraordinary General Meeting and including certain matters in its agenda." This action is initiated by a major shareholder (ANABAZA RAIF V.C.I.C Limited) to the Management Board of Mercator Medical S.A. The content details the formal request for an EGM and lists proposed agenda items (opening the meeting, verifying quorum, approving the agenda). This type of formal request or notice related to a shareholder meeting, especially one requesting specific items be added to the agenda, is closely related to the materials used for soliciting votes or informing shareholders about the meeting structure, which aligns best with Proxy Solicitation & Information Statement (PSI) or potentially AGM-R if it were the final notice, but since it is a *request* to convene, it is a precursor. However, given the options, documents related to the formal process of calling a General Meeting (especially an Extraordinary one) and setting its agenda are most closely related to the information provided to shareholders for voting purposes. If this document were the final notice or proxy statement, it would be PSI or DEF 14A. Since it is a formal request to convene an EGM, it is a regulatory/corporate action announcement. Given the options, and the focus on the meeting structure and agenda setting, it is a corporate governance/shareholder meeting document. Since it is not the final AGM presentation (AGM-R) or the proxy solicitation itself (PSI), and it is a formal request, it falls under the general category of corporate governance related to meetings. Given the strong focus on convening a General Meeting, PSI (Proxy Solicitation & Information Statement) is the closest fit as it deals with the mechanics and information surrounding shareholder votes, even if this specific document is the request leading up to the final solicitation. Alternatively, it could be RNS if no better fit exists, but PSI covers shareholder meeting materials well. I will classify it as PSI as it directly concerns the mechanics of a shareholder meeting agenda.
2022-07-01 Polish
Wniosek akcjonariusza o zwołanie Nadzwyczajnego Walnego Zgromadzenia - Content (PL)
AGM Information Classification · 98% confidence The document is a formal announcement by the Management Board ("Zarząd") of Mercator Medical S.A. stating that they received a request from a major shareholder (ANABAZA RAIF V.C.I.C Limited) to convene an Extraordinary General Meeting ("Nadzwyczajnego Walnego Zgromadzenia Spółki"). The request details the proposed agenda items, which primarily concern revoking or amending previous resolutions related to share buybacks, cancellation of shares, and capital reduction. This document is an official notification regarding the process leading up to a shareholder meeting, specifically detailing a request for an EGM agenda. This falls under the scope of general corporate governance and shareholder meeting procedures. Since the text explicitly mentions the request to convene a General Meeting and lists the proposed agenda, it is most closely related to the materials surrounding shareholder meetings. While it is not the final voting result (DVA) or the proxy materials (PSI), it is a direct precursor/announcement related to a General Meeting. Given the options, 'AGM-R' (AGM Information) is the closest fit for materials related to a General Meeting, even if it is an Extraordinary one (EGM), as it deals with the formal proceedings and agenda setting for a shareholder assembly. The document is short and announces the request, which is a type of corporate disclosure, but the subject matter is clearly the General Meeting itself.
2022-07-01 Polish
Informacje udzielone Akcjonariuszowi
AGM Information Classification · 99% confidence The document is a formal letter dated June 23, 2022, addressed to a shareholder of Mercator Medical S.A. It explicitly responds to questions raised during the Annual General Meeting (Zwyczajne Walne Zgromadzenie) held on June 9, 2022, regarding a loan, property details (land registry numbers, valuation), and equity capital. This is a direct response to shareholder inquiries made during a general meeting, providing specific information requested by attendees. This fits best under 'AGM Information' (AGM-R), as it is a direct follow-up communication concerning matters discussed or raised at the AGM. It is not a general earnings release (ER), a full annual report (10-K), or a standard proxy statement (PSI).
2022-06-24 Polish
Informacje udzielone akcjonariuszowi poza walnym zgromadzeniem, na podstawie art. 428 § 5 Kodeksu spółek handlowych - Content (PL)
AGM Information Classification · 99% confidence The document text is very short (296 characters) and states that the Management Board ('Zarząd') of Mercator Medical S.A. is providing information attached to the current report ('raportu bieżącego') in response to a request made during the Ordinary General Meeting ('Zwyczajnego Walnego Zgromadzenia') on June 23, 2022. This structure—a brief announcement stating that information is attached or being provided in response to a specific event (like an AGM request)—strongly suggests this is an announcement about the release of specific information rather than the full report itself. Since the information relates to proceedings or requests made during the AGM, and it is being released via a current report, the most fitting category is the general Regulatory Filings (RNS) as a fallback, or potentially AGM-R if the content was the actual AGM material, but given the context of 'przekazuje w załączniku do niniejszego raportu bieżącego' (provides in the attachment to this current report), RNS is the safest general regulatory classification for a brief update/attachment notice.
2022-06-24 Polish
Udzielenie pożyczki podmiotowi powiązanemu - Content (PL)
Capital/Financing Update Classification · 95% confidence The document is written in Polish and details a significant financial transaction: a loan (pożyczka) of PLN 52,000,000 granted by a subsidiary (Brestia sp. z o.o.) to another entity (Orpheus sp. z o.o.) which is related to the CEO of the issuer (Mercator Medical S.A.). It specifies the terms, collateral (including mortgages and share pledges), and references a resolution from the Annual General Meeting (Zwyczajnego Walnego Zgromadzenia) authorizing such transactions. This type of disclosure, concerning related-party transactions, financing activities, and capital structure management, most closely aligns with the 'Capital/Financing Update' (CAP) category, as it involves the deployment of significant corporate funds into a related financing arrangement. It is not a standard earnings release (ER), an annual report (10-K), or a simple dividend notice (DIV). Given the nature of the transaction (a large loan to a related party), it falls under significant corporate financing/capital deployment activity.
2022-06-15 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.